Premenstrual dysphoric disorder: Evaluation, pathophysiology and treatment
dc.contributor.author | Haskett, Roger F. | en_US |
dc.date.accessioned | 2006-04-07T20:00:08Z | |
dc.date.available | 2006-04-07T20:00:08Z | |
dc.date.issued | 1987 | en_US |
dc.identifier.citation | Haskett, Roger F. (1987)."Premenstrual dysphoric disorder: Evaluation, pathophysiology and treatment." Progress in Neuro-Psychopharmacology and Biological Psychiatry 11(2-3): 129-135. <http://hdl.handle.net/2027.42/26890> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6TBR-475CF21-116/2/9144597457aadfb1cadc8e7c0536368f | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/26890 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3628825&dopt=citation | en_US |
dc.description.abstract | 1. 1. A small percentage of women describe a prominent dysphoric disturbance that is present during the premenstrual week, remits soon after the onset of menses and produces significant impairment in domestic, social or occupational functioning.2. 2. Premenstrual dysphoric disorder must be distinguished from minor premenstrual emotional changes, from dysmenorrhea and from premenstrual exacerbations of psychiatric illness. Diagnostic evaluation should include the prospective assessment of symptoms over at least two complete menstrual cycles.3. 3. Although the pathophysiology of premenstrual dysphoric disorder is linked to cycling of the intact hypothalamo-pituitary-gonadal axis, many studies have contained serious methodological weaknesses and no single etiological theory has received widespread support.4. 4. No single pharmacological treatment has been shown to be clearly more effective than placebo in controlled studies and premenstrual dysphoric disorder appears to respond favorably to most interventions in uncontrolled studies. Interruption of pituitary-ovarian cycling will alleviate premenstrual symptoms, but treatments of this type cannot be recommended for general use until potential hazards are clarified. | en_US |
dc.format.extent | 588949 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Premenstrual dysphoric disorder: Evaluation, pathophysiology and treatment | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 3628825 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/26890/1/0000456.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0278-5846(87)90050-9 | en_US |
dc.identifier.source | Progress in Neuro-Psychopharmacology and Biological Psychiatry | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.